1
|
Mitchell TC, Feng NL, Lam YT, Michael P, Santos M, Wise SG. Engineering vascular bioreactor systems to closely mimic physiological forces in vitro. TISSUE ENGINEERING PART B: REVIEWS 2022. [DOI: 10.1089/ten.teb.2022.0158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Timothy C Mitchell
- The University of Sydney, 4334, School of Medical Sciences, Sydney, New South Wales, Australia,
| | - Nicolas L Feng
- The University of Sydney, 4334, School of Medical Sciences, Sydney, New South Wales, Australia,
| | - Yuen Ting Lam
- The University of Sydney, 4334, School of Medical Sciences, Sydney, New South Wales, Australia,
| | - Praveesuda Michael
- The University of Sydney, 4334, School of Medical Sciences, Sydney, New South Wales, Australia,
| | - Miguel Santos
- The University of Sydney, 4334, School of Medical Sciences, Sydney, New South Wales, Australia,
| | - Steven G Wise
- The University of Sydney, 4334, School of Medical Sciences, Sydney, New South Wales, Australia,
| |
Collapse
|
2
|
Mirhaidari GJ, Barker JC, Zbinden JC, Santantonio BM, Chang YC, Best CA, Reinhardt JW, Blum KM, Yi T, Breuer CK. Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis. Adv Healthc Mater 2020; 9:e2001094. [PMID: 33073543 PMCID: PMC7936649 DOI: 10.1002/adhm.202001094] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 09/28/2020] [Indexed: 01/07/2023]
Abstract
Tissue engineered vascular grafts (TEVGs) are a promising technology, but are hindered by occlusion. Seeding with bone-marrow derived mononuclear cells (BM-MNCs) mitigates occlusion, yet the precise mechanism remains unclear. Seeded cells disappear quickly and potentially mediate an anti-inflammatory effect through paracrine signaling. Here, a series of reciprocal genetic TEVG implantations plus recombinant protein treatment is reported to investigate what role interleukin-10, an anti-inflammatory cytokine, plays from both host and seeded cells. TEVGs seeded with BM-MNCs from wild-type and IL-10 KO mice, plus unseeded grafts, are implanted into wild-type and IL-10 KO mice. Wild-type mice with unseeded grafts also receive recombinant IL-10. Serial ultrasound evaluates occlusion and TEVGs are harvested at 14 d for immunohistochemical analysis. TEVGs in IL-10 KO mice have significantly higher occlusion incidence compared to wild-type mice attributed to acute (<3 d) thrombosis. Cell seeding rescues TEVGs in IL-10 KO mice comparable to wild-type patency. IL-10 from the host and seeded cells do not significantly influence graft inflammation and macrophage phenotype, yet IL-10 treatment shows interesting biologic effects including decreasing cell proliferation and increasing M2 macrophage polarization. IL-10 from the host is critical for preventing TEVG thrombosis and seeded BM-MNCs exert a significant anti-thrombotic effect in IL-10 KO mice.
Collapse
Affiliation(s)
- Gabriel J.M. Mirhaidari
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Jenny C. Barker
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Jacob C. Zbinden
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Brevan M. Santantonio
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Yu-Chun Chang
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Cameron A. Best
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - James W. Reinhardt
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Kevin M. Blum
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Tai Yi
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| | - Christopher K. Breuer
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, 575 Children’s Crossroad, Research III, WB4160 A1, Columbus, OH, 43215, United States of America
| |
Collapse
|
3
|
Rambøl MH, Hisdal J, Sundhagen JO, Brinchmann JE, Rosales A. Recellularization of Decellularized Venous Grafts Using Peripheral Blood: A Critical Evaluation. EBioMedicine 2018; 32:215-222. [PMID: 29779699 PMCID: PMC6020714 DOI: 10.1016/j.ebiom.2018.05.012] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2018] [Revised: 04/29/2018] [Accepted: 05/08/2018] [Indexed: 01/08/2023] Open
Abstract
Vascular disease is a major cause of death worldwide, and the growing need for replacement vessels is not fully met by autologous grafts or completely synthetic alternatives. Tissue engineering has emerged as a compelling strategy for the creation of blood vessels for reconstructive surgeries. One promising method to obtain a suitable vessel scaffold is decellularization of donor vascular tissue followed by recellularization with autologous cells. To prevent thrombosis of vascular grafts, a confluent and functional autologous endothelium is required, and researchers are still looking for the optimal cell source and recellularization procedure. Recellularization of a decellularized scaffold with only a small volume of whole blood was recently put forward as a feasible option. Here we show that, in contrast to the published results, this method fails to re-endothelialize decellularized veins. Only occasional nucleated cells were seen on the luminal surface of the scaffolds. Instead, we saw fibrin threads, platelets and scattered erythrocytes. Molecular remnants of the endothelial cells were still attached to the scaffold, which explains in part why earlier results were misinterpreted. Decellularized vascular tissues may still be the best scaffolds available for vascular tissue engineering. However, for the establishment of an adequate autologous endothelial lining, methods other than exposure to autologous whole blood need to be developed.
Collapse
Affiliation(s)
- Mia H Rambøl
- Norwegian center for stem cell research, Department of immunology, Oslo university hospital, Oslo, Norway; Oslo vascular center, Department of vascular surgery, Oslo university hospital, Oslo, Norway.
| | - Jonny Hisdal
- Oslo vascular center, Department of vascular surgery, Oslo university hospital, Oslo, Norway
| | - Jon O Sundhagen
- Oslo vascular center, Department of vascular surgery, Oslo university hospital, Oslo, Norway
| | - Jan E Brinchmann
- Norwegian center for stem cell research, Department of immunology, Oslo university hospital, Oslo, Norway; Department of molecular medicine, University of Oslo, Oslo, Norway
| | - Antonio Rosales
- Oslo vascular center, Department of vascular surgery, Oslo university hospital, Oslo, Norway
| |
Collapse
|
4
|
Akintewe OO, Roberts EG, Rim NG, Ferguson MA, Wong JY. Design Approaches to Myocardial and Vascular Tissue Engineering. Annu Rev Biomed Eng 2017; 19:389-414. [DOI: 10.1146/annurev-bioeng-071516-044641] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Olukemi O. Akintewe
- Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215;, ,
| | - Erin G. Roberts
- Division of Materials Science and Engineering, Boston University, Boston, Massachusetts 02215;,
| | - Nae-Gyune Rim
- Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215;, ,
| | - Michael A.H. Ferguson
- Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215;, ,
| | - Joyce Y. Wong
- Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215;, ,
- Division of Materials Science and Engineering, Boston University, Boston, Massachusetts 02215;,
| |
Collapse
|
5
|
Feil G, Horres R, Schulte J, Mack AF, Petzoldt S, Arnold C, Meng C, Jost L, Boxleitner J, Kiessling-Wolf N, Serbest E, Helm D, Kuster B, Hartmann I, Korff T, Hahne H. Bacterial Cellulose Shifts Transcriptome and Proteome of Cultured Endothelial Cells Towards Native Differentiation. Mol Cell Proteomics 2017. [PMID: 28637836 DOI: 10.1074/mcp.ra117.000001] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Preserving the native phenotype of primary cells in vitro is a complex challenge. Recently, hydrogel-based cellular matrices have evolved as alternatives to conventional cell culture techniques. We developed a bacterial cellulose-based aqueous gel-like biomaterial, dubbed Xellulin, which mimics a cellular microenvironment and seems to maintain the native phenotype of cultured and primary cells. When applied to human umbilical vein endothelial cells (HUVEC), it allowed the continuous cultivation of cell monolayers for more than one year without degradation or dedifferentiation. To investigate the impact of Xellulin on the endothelial cell phenotype in detail, we applied quantitative transcriptomics and proteomics and compared the molecular makeup of native HUVEC, HUVEC on collagen-coated Xellulin and collagen-coated cell culture plastic (polystyrene).Statistical analysis of 12,475 transcripts and 7831 proteins unveiled massive quantitative differences of the compared transcriptomes and proteomes. K-means clustering followed by network analysis showed that HUVEC on plastic upregulate transcripts and proteins controlling proliferation, cell cycle and protein biosynthesis. In contrast, HUVEC on Xellulin maintained, by and large, the expression levels of genes supporting their native biological functions and signaling networks such as integrin, receptor tyrosine kinase MAP/ERK and PI3K signaling pathways, while decreasing the expression of proliferation associated proteins. Moreover, CD34-an endothelial cell differentiation marker usually lost early during cell culture - was re-expressed within 2 weeks on Xellulin but not on plastic. And HUVEC on Xellulin showed a significantly stronger functional responsiveness to a prototypic pro-inflammatory stimulus than HUVEC on plastic.Taken together, this is one of the most comprehensive transcriptomic and proteomic studies of native and propagated HUVEC, which underscores the importance of the morphology of the cellular microenvironment to regulate cellular differentiation, and demonstrates, for the first time, the potential of Xellulin as versatile tool promoting an in vivo-like phenotype in primary and propagated cell culture.
Collapse
Affiliation(s)
- Gerhard Feil
- From the ‡Xellutec GmbH, Eichenstraβe 15, 82061 Neuried, Germany
| | - Ralf Horres
- §GenXPro GmbH, Altenhöferallee 3, 60438 Frankfurt am Main, Germany
| | - Julia Schulte
- From the ‡Xellutec GmbH, Eichenstraβe 15, 82061 Neuried, Germany
| | - Andreas F Mack
- ¶Institute of Clinical Anatomy and Cell Analysis, University of Tübingen, Österbergstraβe 3, 72074 Tübingen, Germany
| | - Svenja Petzoldt
- ‖OmicScouts GmbH, Emil-Erlenmeyer-Forum 5, 85354 Freising, Germany
| | - Caroline Arnold
- **Institute of Physiology and Pathophysiology, Division of Cardiovascular Physiology, University of Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany
| | - Chen Meng
- ‡‡Chair of Proteomics and Bioanalytics, Technische Universität München, Emil-Erlenmeyer-Forum 5, 85354 Freising, Germany
| | - Lukas Jost
- §GenXPro GmbH, Altenhöferallee 3, 60438 Frankfurt am Main, Germany
| | | | | | - Ender Serbest
- From the ‡Xellutec GmbH, Eichenstraβe 15, 82061 Neuried, Germany
| | - Dominic Helm
- ‖OmicScouts GmbH, Emil-Erlenmeyer-Forum 5, 85354 Freising, Germany
| | - Bernhard Kuster
- ‡‡Chair of Proteomics and Bioanalytics, Technische Universität München, Emil-Erlenmeyer-Forum 5, 85354 Freising, Germany.,§§Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technische Universität München, Gregor-Mendel-Strasse 4, 85354 Freising, Germany
| | - Isabel Hartmann
- From the ‡Xellutec GmbH, Eichenstraβe 15, 82061 Neuried, Germany
| | - Thomas Korff
- §§Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technische Universität München, Gregor-Mendel-Strasse 4, 85354 Freising, Germany
| | - Hannes Hahne
- ‖OmicScouts GmbH, Emil-Erlenmeyer-Forum 5, 85354 Freising, Germany;
| |
Collapse
|
6
|
|